Part 1: Symptom control in the management of fungating wounds

World Wide Wounds

Volumn 2002, Issue , 2002, Pages

  Naylor, Wayne ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Bleeding; Exudate; Fungating wounds; Malodour; Pain; Symptom control

Indexed keywords

ADRENALIN; ALGINIC ACID; ANABACT; ANALGESIC AGENT; ANTIBIOTIC AGENT; DIAMORPHINE; METRONIDAZOLE; METROTOP; MORPHINE; OPIATE; SUCRALFATE; TRANEXAMIC ACID;

ADVANCED CANCER; ALCOHOL INTOLERANCE; BLEEDING; DEBRIDEMENT; DISEASE CONTROL; DISEASE DURATION; EXUDATE; HUMAN; NAUSEA; NEUROPATHY; ODOR CONTROL; PAIN; PALLIATIVE THERAPY; PROTECTIVE CLOTHING; QUALITY OF LIFE; REVIEW; SURGICAL SPONGE; SYMPTOMATOLOGY; WOUND; WOUND CARE; WOUND DRESSING; WOUND HEALING;

EID: 4043099048     PISSN: 13692607     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Mortimer PS. Management of skin problems: medical aspects In: Doyle D, Hanks GWC, MacDonald N, editors. Oxford Textbook of Palliative Medicine (2nd edition). Oxford: Oxford University Press, 1998; 617-27.
2. Englund F. Wound management in palliative care. RCN Contact 1993; Winter: 2-3.
3. Grocott P. The palliative management of fungating malignant wounds. J Wound Care 1995; 4(5): 240-2.
4. Bycroft L. Care of a handicapped woman with metastatic breast cancer. Br J Nurs 1994; 3(3): 126-8, 130-3.
5. Grocott P. The management of fungating wounds. J Wound Care 1999; 8(5): 232-4.
6. Collier M. The assessment of patients with malignant fungating wounds - a holistic approach: Part 1. Nurs Times 1997; 93(44): suppl 1-4.
7. Young T. The challenge of managing fungating wounds. Community Nurse 1997; 3(9): 41-4.
8. Carville K. Caring for cancerous wounds in the community. J Wound Care 1995; 4(2): 66-8.
9. Malheiro E, Pinto A, Choupina M, Barroso L, Reis J, Amarabte J. Marjolin ulcer of the scalp: case report and literature review. Annals of Burns and Fire Disasters (online) 2001; 14(1): Available from URL: http://www.medbc.com/annals/review/vol_14/num_1/text/v14n1p39.htm [Accessed 28 November 2001].
10. Esther RJ, Lamps L, Schwartz HS. Marjolin ulcers: secondary carcinomas in chronic wounds. J Southern Orthopaedic Assoc 1999; 8(3): 181-87.
11. Hill BB, Sloan DA, Lee EY, McGrath PC, Kenady DE. Marjolin's ulcer of the foot caused by nonburn trauma. South Med J 1996; 89(7): Available from URL: http://www.sma.org/smj/96jul11.htm [Accessed 28 November 2001].
12. Haisfield-Wolfe ME, Rund C. Malignant cutaneous wounds: a management protocol. Ostomy Wound Manage 1997; 43(1): 56-60, 62, 64-6.
13. Ivetic O, Lyne PA. Fungating and ulcerating malignant lesions: a review of the literature. J Adv Nurs 1990; 15(1): 83-8.
14. Thomas S. Current Practices in the Management of Fungating Lesions and Radiation Damaged Skin. Bridgend, Mid Glamorgan: The Surgical Materials Testing Laboratory, 1992.
15. Collier M. The assessment of patients with malignant fungating wounds - a holistic approach: Part 2. Nurs Times 1997; 93(46): suppl 1-4.
16. Goodman M, Hilderley LJ, Purl S. Integumentary and mucous membrane alterations In: Groenwald SL, Hansen Frogge M, Goodman M, Henk Yarbro C, editors. Cancer Nursing: Principles and Practice (4th edition). Massachusetts: Jones and Bartlett, 1997; 768-822.
17. Bale S, Jones V. Wound Care Nursing. A Patient Centred Approach. London: Baillere Tindall, 1997.
18. Hallett A. Fungating wounds. Nurs Times 1995; 91(47): 81-83.
19. Haughton W, Young T. Common problems in wound care: malodorous wounds. Br J Nurs 1995; 4(16): 959-60, 962-3.
20. Pudner R. The management of patients with fungating or malignant wound. J Community Nursing (online) 1998; 12(9): Available from URL: http://www.jcn.co.uk/backiss.asp?YearNum=1998&MonthNum= 09&ArticleID=82 [Accessed 18 February 2000].
21. Jones M, Davey J, Champion M. Dressing wounds. Nurs Stand 1998; 12(39): 47-52; quiz 55-6.
22. Laverty D, Cooper J, Soady S. Wound management. In: Mallet J, Dougherty L, editors. The Royal Marsden Hospital Manual of Clinical Nursing Procedures (5th edition). Oxford: Blackwell Scientific Ltd, 2000; 681-710.
23. Ingham J, Portenoy RK. The measurement of pain and other symptoms In: Doyle SL, Hanks GWC, MacDonald N, editors. Oxford Textbook of Palliative Medicine (2nd edition). Oxford: Oxford University Press, 1998; 203-19.
24. Samarel N, Leddy SK, Greco K, Cooley ME, Torres SC, Tulman L, Fawcett J. Development and testing of the symptom experience scale. J Pain Symptom Manage 1996; 12(4): 221-8.
25. Price E. Wound care. The stigma of smell. Nurs Times 1996; 92(20): 70-2.
26. Fairburn K. A challenge that requires further research: management of fungating breast lesions. Professional Nurse 1994; 9(4): 272-77.
27. Gallagher J. Management of cutaneous symptoms. Semin Oncol Nurs 1995; 11(4): 239-47.
28. Van Toller S. Invisible wounds: the effects of skin ulcer malodours. J Wound Care 1994; 3(2): 103-05.
29. Davis V. Goal-setting aids care. Nurs Times 1995; 91(39): 72, 74, 76.
30. Boardman M, Mellor K, Neville B. Treating a patient with a heavily exuding malodorous fungating ulcer. J Wound Care 1993; 2(2): 74-76.
31. Grocott P. Wound care - practical changes. Nurs Times 1993; 89(7): 64, 66, 68 passim.
32. Manning MP. Metastasis to skin. Semin Oncol Nurs 1998; 14(3): 240-3.
33. Saunders S. Mutual support. Nurs Times 1997; 93(32): 76-82.
34. Grocott P. The palliative management of fungating wounds. In: Educational booklet Huntingdon: Wound Care Society, 2001.
35. Bower M, Stein R, Evans TR, Hedley A, Pert P, Coombes RC. A double-blind study of the efficacy of metronidazole gel in the treatment of malodorous fungating tumours. Eur J Cancer 1992; 28A(4-5): 888-9.
36. Newman V, Allwood M, Oakes RA. The use of metronidazole gel to control the smell of malodorous lesions. Palliative Medicine 1989; 34: 303-05.
37. Ashford RF, Plant GT, Maher J, Pickering D, Coe MA, Drury A, Goold MA, Teare EL. Metronidazole in smelly tumours. Lancet 1980; 1(8173): 874-5.
38. Hampton JP. The use of metronidazole in the treatment of malodorous wounds. J Wound Care 1996; 5(9): 421-26.
39. Thomas S, Fisher B, Fram PJ, Waring MJ. Odour-absorbing dressings. J Wound Care 1998; 7(5): 246-50.
40. Gilchrist B. Wound infection In: Miller M, Glover D, editors. Wound Management Theory and Practice. London: Nursing Times Books, 1999; 96-106.
41. Cutting K. Wounds and infection. In: Educational leaflet Huntingdon: Wound Care Society, 1998.
42. Williams C. Clinisorb activated charcoal dressing for odour control. Br J Nurs 1999; 8(15): 1016-19.
43. Edwards J. Wound management (2): managing malodorous wounds. J Community Nursing (online) 2000; 14(4): Available from URL: http://www.jcn.co.uk/backiss.asp?YearNum=2000&MonthNum= 04&ArticleID=136 [Accessed 2 July 2001].
44. Cooper R, Molan P. The use of honey as an antiseptic in managing Pseudomonas infection. J Wound Care 1999; 8(4): 161-4.
45. Molan PC. The role of honey in the management of wounds. J Wound Care 1999; 8(8): 415-8.
46. Morgan DA. Formulary of Wound Management Products: A Guide for Healthcare Staff (8th edition). Surrey, UK: Euromed Communciations Ltd, 2000.
47. Molan PC. Honey as a topical antibacterial agent for treatment of infected wounds. World Wide Wounds (online) 2001; Available from URL: http://www.worldwidewounds.com/2001/november/Molan/ honey-as-topical-agent.html [Accessed February 2002].
48. Naylor W, Laverty D, Mallett J. The Royal Marsden Hospital Handbook of Wound Management in Cancer Care. Oxford: Blackwell Science Ltd, 2001.
49. Naylor W. Using a new foam dressing in the care of fungating wounds. Br J Nursing 2001; 10(6): Suppl S24-S30.
50. Grocott P. Exudate management in fungating wounds. J Wound Care 1998; 7(9): 445-8.
51. World Health Organisation. Cancer Pain Relief (2nd edition). Geneva: WHO, 1996.
52. Travis S. Entonox administration In: Mallet J, Dougherty L, editors. The Royal Marsden Hospital Manual of Clinical Nursing Procedures (5th edition). Oxford: Blackwell Science Ltd, 2000; 261-65.
53. Emflorgo CA. The assessment and treatment of wound pain. J Wound Care 1999; 8(8): 384-5.
54. Hollinworth H. Wound care - less pain, more gain. Nurs Times 1997; 93(46): 89-91.
55. Ryman L, Rankin-Box D. Relaxation and visualisation In: Rankin-Box J, editor. The Nurse's Handbook of Complementary Therapies (2nd edition). London: Balliere Tindall, 2001; 251-58.
56. Downing J. Pain in the Patient with Cancer, Nursing Times Clinical Monographs No5. London: NT Books, 1999.
57. Stein C. The control of pain in peripheral tissue by opioids. N Engl J Med 1995; 332(25): 1685-90.
58. Twillman RK, Long TD, Cathers TA, Mueller DW. Treatment of painful skin ulcers with topical opioids. J Pain Symptom Manage 1999; 17(4): 288-92.
59. Back IN, Finlay I. Analgesic effect of topical opioids on painful skin ulcers. J Pain Symptom Manage 1995; 10(7): 493.
60. Krajnik M, Zylicz Z. Topical morphine for cutaneous cancer pain. Palliat Med 1997; 11(4): 325.
61. Grocott P. Palliative management of fungating malignant wounds. J Community Nursing (online) 2000; 14(3): Available from URL: http://www.jcn.co.uk/backiss.asp?YearNum=2000&MonthNum= 03&ArticleID=221 [Accessed 15 June 2001].
62. Miller C. Management of skin problems: nursing aspects In: Doyle D, Hanks GWC, MacDonald N, editors. Oxford Textbook of Palliative Medicine (2nd edition). Oxford: Oxford University Press, 1998; 642-56.
63. Thomas S, Vowden K, Newton H. Controlling bleeding in fragile fungating wounds. J Wound Care 1998; 7(3): 154.
64. Emflorgo CA. Controlling bleeding in fungating wounds. J Wound Care 1998; 7(5): 235.
65. Grocott P. Controlling bleeding in fragile fungating tumours. J Wound Care 1998; 7(7): 342.